Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives

Cells(2024)10.3390/cells13090726Source: DataRank Database

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives is a research paper published in Cells (2024). On theSindex it has a DataRank of 0. It has been cited 35 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access35 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.72)OA: goldTopics (68)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Marco Gallus ORCID,Su Phyu ORCID,Jeffrey Haegelin,John de Groot ORCID,Hideho Okada ORCID

Live enrichment

PubMed:38727262 PMC:PMC11083543 OpenAlex:https://openalex.org/W4395041149

NIH/NINDS

Grant: R35NS105068

NIH/NINDS

Grant: GA3535/1

National Institutes of Health

Grant: 5R35NS105068-05

Preclinical development of breakthrough immunotherapy for brain tumors

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

FWCI

6.72

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/13/9/726/pdf?version=1713863392

publisherhttps://www.mdpi.com/2073-4409/13/9/726/pdf?version=1713863392

publisherhttps://www.mdpi.com/2073-4409/13/9/726/pdf

journalhttps://doi.org/10.3390/cells13090726

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38727262

Fields of Study

CAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design0301 basic medicine03 medical and health sciences0303 health sciencesHumansGlioblastomaImmunotherapy, AdoptiveReceptors, Chimeric AntigenTumor MicroenvironmentBrain NeoplasmsT-LymphocytesAnimals

MeSH Terms

Receptors, Chimeric AntigenAnimalsBrain NeoplasmsGlioblastomaHumansT-LymphocytesImmunotherapy, AdoptiveTumor Microenvironment

Keywords

Chimeric antigen receptorMedicineImmunosuppressionCell therapyTumor microenvironmentGlioblastomaImmune systemT cellImmunotherapyBrain tumorImmune surveillanceOncologyCancer researchImmunologyCellPathologyBiologyTumor Immune MicroenvironmentCar-t-cell TherapyBiomedical and clinical sciencesT-LymphocytesOncology and CarcinogenesisAdoptive610ReviewImmunotherapy, AdoptiveRare DiseasesReceptorsGeneticsHumansAnimalsCancerReceptors, Chimeric AntigenQH573-671Brain NeoplasmsNeurosciencesChimeric AntigenGene TherapyBrain DisordersBrain CancerBiological sciencesOrphan DrugGood Health and Well Being5.1 PharmaceuticalsCytologyBiotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)